Behavioral characterization of Alzheimer's disease (AD) transgenic models over multiple
time points during aging has been largely inadequate, usually being limited to one or two …

Several transgenic mouse models for Alzheimer's disease (AD) that develop β-amyloid
deposition have recently been advanced, including the Tg2576 mouse. Thorough …

The Tg2576 mouse model of excessive cerebral β-amyloid deposition is now more than a
decade old, yet consensus as to its exact characteristics and utility as a model of Alzheimer's …

Transgenic mouse models of Alzheimer's disease (AD) have been recently advanced.
Tg2576 mice have been shown to develop progressive β-amyloid (Aβ) neuritic plaques and …

The transgenic mouse Tg2576 is widely used as a murine model of Alzheimer's disease
(AD) and exhibits plaque pathogenesis in the brain and progressive memory impairments …

In a previous publication [Deacon RMJ, Cholerton LL, Talbot K, Nair-Roberts RG,
Sanderson DJ, Romberg C, et al. Age-dependent and-independent behavioral deficits in …

The transgenic Tg2576 mouse is a widely used animal model that develops some of the
cognitive and neuropathological deteriorations observed in patients suffering Alzheimer's …

The TgF344 rat model of Alzheimer's disease (AD) provides a comprehensive
neuropathology presentation, with age-dependent development of tau tangles, amyloid-beta …

Alzheimer's disease (AD) is not only characterized by cognitive decline and
neuropathological changes, but also by non-cognitive behavioral symptoms like …

Transgenic Tg2576 mice overexpressing human amyloid precursor protein (hAPP) are a
widely used Alzheimer's disease (AD) mouse model to evaluate treatment effects on amyloid …